Diagnio is a UAE-based innovative HealthTech startup with a mission to transform hormonal diagnostics and help women get a clear understanding of their reproductive health through an accessible, accurate, and comfortable at-home test system. Diagnio generation one device uses a sample of female saliva to measure estrogen levels and determine the cycle phase and ovulation via mobile application. Our team is super experienced in both the startup and corporate worlds, with 15+ years of experience in HealthTech and 5+ years in Medical devices. Our generation one product already has FDA Class 1 clearance, and our startup is backed by Alchemist & ExpertDOJO accelerators in US and IN5 & NRG Ventures in UAE and KSA.
Total Fundraised$5B
Content Locked
Login or Register a FREE account to continue browsing our content
Content Locked
Login or Register a FREE account to continue browsing our content
Funding Round | Announced Date | Disclosed Investors | Round Amount (USD) |
---|
Content Locked
Login or Register a FREE account to continue browsing our content